S&P 500   4,244.35 (-0.68%)
DOW   33,334.24 (-0.85%)
QQQ   352.50 (-0.48%)
AAPL   169.56 (-1.40%)
MSFT   310.82 (-0.42%)
META   298.27 (-0.23%)
GOOGL   129.38 (+0.63%)
AMZN   124.81 (-0.93%)
TSLA   235.19 (-3.66%)
NVDA   417.89 (-0.29%)
NIO   8.33 (-0.95%)
BABA   85.51 (-0.47%)
AMD   97.01 (+1.09%)
T   14.85 (-1.13%)
F   12.30 (-1.05%)
MU   67.12 (-1.21%)
CGC   0.86 (-6.73%)
GE   110.69 (+0.69%)
DIS   79.26 (-0.99%)
AMC   7.72 (-2.40%)
PFE   31.93 (-1.45%)
PYPL   56.88 (-3.48%)
NFLX   377.25 (-0.53%)
S&P 500   4,244.35 (-0.68%)
DOW   33,334.24 (-0.85%)
QQQ   352.50 (-0.48%)
AAPL   169.56 (-1.40%)
MSFT   310.82 (-0.42%)
META   298.27 (-0.23%)
GOOGL   129.38 (+0.63%)
AMZN   124.81 (-0.93%)
TSLA   235.19 (-3.66%)
NVDA   417.89 (-0.29%)
NIO   8.33 (-0.95%)
BABA   85.51 (-0.47%)
AMD   97.01 (+1.09%)
T   14.85 (-1.13%)
F   12.30 (-1.05%)
MU   67.12 (-1.21%)
CGC   0.86 (-6.73%)
GE   110.69 (+0.69%)
DIS   79.26 (-0.99%)
AMC   7.72 (-2.40%)
PFE   31.93 (-1.45%)
PYPL   56.88 (-3.48%)
NFLX   377.25 (-0.53%)
S&P 500   4,244.35 (-0.68%)
DOW   33,334.24 (-0.85%)
QQQ   352.50 (-0.48%)
AAPL   169.56 (-1.40%)
MSFT   310.82 (-0.42%)
META   298.27 (-0.23%)
GOOGL   129.38 (+0.63%)
AMZN   124.81 (-0.93%)
TSLA   235.19 (-3.66%)
NVDA   417.89 (-0.29%)
NIO   8.33 (-0.95%)
BABA   85.51 (-0.47%)
AMD   97.01 (+1.09%)
T   14.85 (-1.13%)
F   12.30 (-1.05%)
MU   67.12 (-1.21%)
CGC   0.86 (-6.73%)
GE   110.69 (+0.69%)
DIS   79.26 (-0.99%)
AMC   7.72 (-2.40%)
PFE   31.93 (-1.45%)
PYPL   56.88 (-3.48%)
NFLX   377.25 (-0.53%)
S&P 500   4,244.35 (-0.68%)
DOW   33,334.24 (-0.85%)
QQQ   352.50 (-0.48%)
AAPL   169.56 (-1.40%)
MSFT   310.82 (-0.42%)
META   298.27 (-0.23%)
GOOGL   129.38 (+0.63%)
AMZN   124.81 (-0.93%)
TSLA   235.19 (-3.66%)
NVDA   417.89 (-0.29%)
NIO   8.33 (-0.95%)
BABA   85.51 (-0.47%)
AMD   97.01 (+1.09%)
T   14.85 (-1.13%)
F   12.30 (-1.05%)
MU   67.12 (-1.21%)
CGC   0.86 (-6.73%)
GE   110.69 (+0.69%)
DIS   79.26 (-0.99%)
AMC   7.72 (-2.40%)
PFE   31.93 (-1.45%)
PYPL   56.88 (-3.48%)
NFLX   377.25 (-0.53%)
OTCMKTS:AFFY

Affymax (AFFY) Stock Forecast, Price & News

$0.0042
0.00 (0.00%)
(As of 09/26/2023 ET)
Compare
Today's Range
$0.0042
$0.0042
50-Day Range
N/A
52-Week Range
$0.00
$0.04
Volume
N/A
Average Volume
666 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AFFY stock logo

About Affymax (OTCMKTS:AFFY) Stock

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

AFFY Price History

AFFY Stock News Headlines

The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
4 Biotech Stocks Under $5 to Watch
10 Biotech Stocks on Clinical Trials Watch
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Esso Thailand PCL F (ESSOf)
Dialog Group Bhd (DIAL)
DPS Resources Bhd (DPSS)
Affymax IncShs - Profile
Affymax Inc.
See More Headlines
Receive AFFY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Affymax and its competitors with MarketBeat's FREE daily newsletter.

AFFY Company Calendar

Today
9/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
OTCMKTS:AFFY
CUSIP
00826A10
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
5.70
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Mark G. Thompson (Age 61)
    CFO & Sec.
    Comp: $97.49k
  • Mr. Jonathan M. Couchman (Age 53)
    CEO, Pres & Director
  • Dr. Tracy J. Dunn Ph.D. (Age 60)
    J.D., VP of Intellectual Property & Legal Affairs













AFFY Stock - Frequently Asked Questions

How have AFFY shares performed in 2023?

Affymax's stock was trading at $0.0040 on January 1st, 2023. Since then, AFFY shares have increased by 5.0% and is now trading at $0.0042.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Affymax own?
What is Affymax's stock symbol?

Affymax trades on the OTCMKTS under the ticker symbol "AFFY."

How do I buy shares of Affymax?

Shares of AFFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Affymax's stock price today?

One share of AFFY stock can currently be purchased for approximately $0.00.

How can I contact Affymax?

Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The official website for the company is www.affymax.com. The biopharmaceutical company can be reached via phone at (650) 812-8700, via email at investors@affymax.com, or via fax at 650-424-0832.

This page (OTCMKTS:AFFY) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -